Isoindolone derivatives, a new class of 5-HT2C antagonists:: Synthesis and biological evaluation

被引:51
作者
Hamprecht, Dieter
Micheli, Fabrizio
Tedesco, Giovanna
Checchia, Anna
Donati, Daniele
Petrone, Marcella
Terreni, Silvia
Wood, Martyn
机构
[1] GlaxoSmithKline Inc, Med Res Ctr, I-37135 Verona, Italy
[2] GlaxoSmithKline Inc, Harlow CM19 5AW, Essex, England
关键词
serotonin receptors; 5-HT receptors; 5-HT2C receptor antagonists; fused rings; vinylic and aromatic double bonds; antidepressant; anxiolytic agent; in silico screening;
D O I
10.1016/j.bmcl.2006.10.029
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Two independent approaches resulted in the identification of a series of isoindolone derivatives as potent and selective 5-HT2C antagonists. From a Medicinal Chemistry perspective this template was considered interesting as it allowed the incorporation of the carbon-carbon double bond of an earlier dihydropyrrolone series in an aromatic system within a comparatively simple and compact motif. Additionally an in silico screening approach of the corporate database using a 5-HT2C pharmacophore model resulted in the identification of a related structure containing this template. The strategy used to optimise potency at the target receptor and to improve the pharmacokinetic profile is described, resulting in molecules combining high potency with good selectivity and oral bioavailability. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:428 / 433
页数:6
相关论文
共 18 条
[1]   A review of central 5-HT receptors and their function [J].
Barnes, NM ;
Sharp, T .
NEUROPHARMACOLOGY, 1999, 38 (08) :1083-1152
[2]  
BLANEY F, 2006, LIGAND DESIGN G PROT, pCH11
[3]  
BONANOMI G, 2004, Patent No. 2004089897
[4]   1-[2-[(heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orally active 5-HT2C receptor inverse agonists [J].
Bromidge, SM ;
Davies, S ;
Duckworth, DM ;
Forbes, IT ;
Jones, GE ;
Jones, J ;
King, FD ;
Blackburn, TP ;
Holland, V ;
Kennett, GA ;
Lightowler, S ;
Middlemiss, DN ;
Riley, GJ ;
Trail, B ;
Wood, MD .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (16) :1867-1870
[5]   Biarylcarbamoylindolines are novel and selective 5-HT2C receptor inverse agonists:: Identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent [J].
Bromidge, SM ;
Dabbs, S ;
Davies, DT ;
Davies, S ;
Duckworth, DM ;
Forbes, IT ;
Gaster, LM ;
Ham, P ;
Jones, GE ;
King, FD ;
Mulholland, KR ;
Saunders, DV ;
Wyman, PA ;
Blaney, FE ;
Clarke, SE ;
Blackburn, TP ;
Holland, V ;
Kennett, GA ;
Lightowler, S ;
Middlemiss, DN ;
Trail, B ;
Riley, GJ ;
Wood, MD .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (06) :1123-1134
[6]  
BROMIDGE SM, 2003, Patent No. 20030107
[7]  
BROMIDGE SM, 2002, Patent No. 20010809
[8]  
Gaster L. M., 1996, PCT Int. Appl., Patent No. [WO 9623783 Al, 9623783]
[9]  
GASTER LM, 1996, Patent No. 9623769
[10]   A series of bisaryl imidazolidin-2-ones has shown to be selective and orally active 5-HT2C receptor antagonists [J].
Goodacre, CJ ;
Bromidge, SM ;
Clapham, D ;
King, FD ;
Lovell, PJ ;
Allen, M ;
Campbell, LP ;
Holland, V ;
Riley, GJ ;
Starr, KR ;
Trail, BK ;
Wood, MD .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (22) :4989-4993